PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Zanthoxylum nitidum ethanol extract (ZNE) significantly improved weight loss, DAI scores, colon shortening, and tissue damage in TNBS-induced UC rat models and protected LPS-stimulated Caco-2 cells [PMID:41055302].
Isoquinoline alkaloids 6-acetonyl-dihydrofagaridine and 6-acetonyl-dihydrochelerythrine showed anti-MRSA bioactivity [PMID:35240520].
Various isolates, including specific isobutylamides, alkaloids, and sesquilignans PD, exhibited inhibitory or cytotoxic effects against human cancer cell lines such as HepG2, T24, and HCC827-osi [PMID:36496049, 41033474, 38958633, 36893545, 36757213].
Evidence summary
PubMed sources
- 1.PMID: 32492492 (2020) — Zanthoxylum nitidum (Roxb.) DC: Traditional uses, phytochemistry, pharmacological activities and toxicology. · Journal of ethnopharmacology
- 2.PMID: 35680557 (2022) — Four New Sesquiterpenoids from Zanthoxylum nitidum. · Chemistry & biodiversity
- 3.PMID: 36496049 (2023) — Structurally diverse isobutylamides from Zanthoxylum nitidum. · Fitoterapia
- 4.PMID: 41055302 (2025) — Zanthoxylum Nitidum Ameliorates Intestinal Barrier Dysfunction and Inflammation in TNBS-Induced Colitis Rats and LPS-Stimulated Caco-2 Cells. · FASEB journal : official publication of the Federation of American Societies for Experimental Biology
- 5.PMID: 37163151 (2023)